A double-blind, randomized, sham-controlled study of Targeted Lung Denervation in patients with moderate to severe COPD

D. Slebos (Groningen, Netherlands), P. Shah (London, United Kingdom), F. Herth (Heidelberg, Germany), C. Pison (Grenoble, France), C. Schumann (Kempten, Germany), R. Kessler (Strasbourg, France), P. Bonta (Amsterdam, Netherlands), W. Gesierich (Gauting, Germany), R. Hubner (Berlin, Germany), K. Darwiche (Essen, Germany), B. Lamprecht (Linz, Austria), T. Perez (Lille, France), D. Skowasch (Bonn, Germany), G. Deslee (Reims, France), A. Valipour (Vienna, Austria)

Source: International Congress 2018 – Interventional pulmonology highlights in 2018: ELVR, TLD and BT
Session: Interventional pulmonology highlights in 2018: ELVR, TLD and BT
Session type: Oral Presentation
Number: 4929
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Slebos (Groningen, Netherlands), P. Shah (London, United Kingdom), F. Herth (Heidelberg, Germany), C. Pison (Grenoble, France), C. Schumann (Kempten, Germany), R. Kessler (Strasbourg, France), P. Bonta (Amsterdam, Netherlands), W. Gesierich (Gauting, Germany), R. Hubner (Berlin, Germany), K. Darwiche (Essen, Germany), B. Lamprecht (Linz, Austria), T. Perez (Lille, France), D. Skowasch (Bonn, Germany), G. Deslee (Reims, France), A. Valipour (Vienna, Austria). A double-blind, randomized, sham-controlled study of Targeted Lung Denervation in patients with moderate to severe COPD. 4929

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: